Health Delivery Performance



Management of Patients with Complex Needs

Academic medical practices serve a valuable role in caring for patients with complex needs and training future internists in the many biopsychosocial components of patient care.

Hopkins Healthcare Business Conference

The Hopkins Healthcare Business Conference is a student produce event aiming to stimulate intellectual engagement, foster active participation, and provide robust networking opportunities for graduate students, academics, and industry leaders. The conference is centered on a commitment to multi-sectoral collaboration to support effective and equitable healthcare innovation. March 7th and 8th

Trust and Health Care-Seeking Behavior

A unique feature of health care markets, recognized by Arrow (1963), is that a physician, the supplier of medical services, is expected to act in the patient’s best interest.

Psychedelics Treatment, Business, and Policy Futures: 8 Expert Takeaways

The application of psychedelic therapy for a range of mental and physical health issues is emerging as a transformative treatment method but federal policy has not kept pace with the industry’s rapid development. To understand the burgeoning business landscape surrounding this innovative therapy, the Hopkins Business of Health Initiative, in partnership with the Center for Mental Health and Addiction Policy, recently convened a panel of national experts to discuss the cutting-edge convergence of psychedelics, business, and policy.  
Research Project

2024 Pilot Grants

HBHI is pleased to announce our five pilot grant awardees for our 2024 cohort.

Why Can't Americans Have Better and Cheaper Health Care? Exploring the Innovation Challenge

Why doesn't healthcare in the US improve in quality while becoming more affordable, as we see in other industries? Join us for an enlightening discussion with James (Jim) and Robert (Bob) Rebitzer, authors of "Why Not Better and Cheaper?" We explored the unique challenges of healthcare innovation in the US, discussing why there's a lack of incentives for cost-reducing innovations and the ease of profiting from low-value innovations. The Rebitzers also shared their perspectives on directing healthcare innovation towards more efficient and cost-effective solutions. This is a crucial conversation for anyone interested in the future of American healthcare.

The Impact of Noncompetes on Healthcare: 7 Expert Takeaways

Non-compete agreements typically restrict employees from joining competitors or starting similar businesses within a given timeframe and geographical area after leaving their jobs. These kinds of covenants have become enormously widespread in the American economy, and even more so in the sector of health care. 

Does Bad Medical News Reduce Preferences for Generic Drugs?

Policy makers and insurers promote the use of generic drugs because they can deliver large savings without sacrificing quality. But these efforts meet resistance from the public, who perceive generic drugs as inferior substitutes for brand name counterparts. Building on literature showing that negative emotions reduce risk-taking, the authors hypothesize that receiving bad medical news (i.e., negative information about one’s health) prompts patients to favor brand name over generic drugs as means to safeguard their health. The evidence exploits low-density lipoprotein cholesterol test results, where a discontinuity from clinical guidelines enables the authors to estimate the causal effect of bad medical news.

WHO Five Moments for Medication Safety: A time to organize?

Since the 2007 landmark report on Preventing Medication Errors from the US National Academy of Medicine, effective interventions have been developed to address medication errors.1 Despite this, medication errors persist as the most common source of harm for patients worldwide.2 In hospitals, adverse drug events are the most common adverse events, accounting in one large study for 39% of all events.3 Medication errors in ambulatory care settings are also an ongoing patient safety challenge.4

Digital Tools Are Putting Effective Behavioral Health Treatments in Patients' Pockets

It’s clear that changes in telehealth policy, mobile technology development, and consumer demand have fundamentally reshaped mental health treatment and substance use care in the US and around the world. What does this mean for people’s outcomes, specifically behavioral health care access, quality, and cost?

Workforce Composition In Private Equity–Acquired Versus Non–Private Equity–Acquired Physician Practices

Despite growth in private equity (PE) acquisitions of physician practices in the US, little is known about how changes in ownership influence workforce composition. Using clinician-level data linked to practice acquisition information, we estimated changes in clinician workforce composition in PE-acquired practice sites relative to non-PE-acquired independent practice sites for dermatology, ophthalmology, and gastroenterology specialties.